Retatrutide and trizepatide represent a recent class of medications that act on both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. These combined receptor https://zoezzgl461020.bloggerchest.com/38799147/new-glp-1-and-gip-receptor-agonists-retatrutide-and-trizepatide